Hostname: page-component-7479d7b7d-wxhwt Total loading time: 0 Render date: 2024-07-08T22:02:41.488Z Has data issue: false hasContentIssue false
  • English
  • Français

Calcitonin Gene Related Peptide Gene Polymorphism in Migraine Patients

Published online by Cambridge University Press:  23 September 2014

Baburhan Guldiken ,
Tammam Sipahi ,
Remziye Tekinarslan ,
Levent Kabayel ,
Hulya Ozkan ,
Ayhan Unlu ,
Bilge Eren Yamasan ,
Tulay Okman-Kilic  and
Nilda Turgut
Baburhan Guldiken*
Affiliation:
Department of Neurology, Trakya University Medical Faculty
Tammam Sipahi
Affiliation:
Department of Biophysics, Trakya University Medical Faculty
Remziye Tekinarslan
Affiliation:
Department of Neurology, Security Hospital of Edirne
Levent Kabayel
Affiliation:
Department of Neurology, Security Hospital of Edirne
Hulya Ozkan
Affiliation:
Department of Neurology, Security Hospital of Edirne
Ayhan Unlu
Affiliation:
Department of Biophysics, Trakya University Medical Faculty
Bilge Eren Yamasan
Affiliation:
Department of Biophysics, Trakya University Medical Faculty
Tulay Okman-Kilic
Affiliation:
Department of Obstetrics and Obstetrics, Trakya University Medical Faculty
Nilda Turgut
Affiliation:
Department of Neurology, Namık Kemal University Medical Faculty, Edirne, Turkey
*
Trakya University Medical Faculty, Department of Neurology, Edirne 22030, Turkey. Email: baburhan@hotmail.com
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Calcitonin gene related peptide (CGRP), which has a vasodilator effect, is held responsible for neurogenic inflammation and vasodilatation of the cranial vessels in migraine pathophysiology. In this study, we investigated the association between alpha CGRP gene polymorphism (CALCA T-692C) and migraine.

Material and Methods:

One hundred and thirty-four female migraineurs and 96 healthy female cases were enrolled in the study. The patient group was further subdivided into migraine with and without aura groups. The CALCA T-692C gene polymorphism was identified using polymerase chain reaction (PCR) technique and restriction fragment length polymorphism (RFLP).

Results:

The genotype and allele frequencies of CALCA T-692C gene polymorphism did not differ between the migraine and control groups. Between the migraine with and without aura subgroups, there was no difference. No association was seen between the CALCA T-692C gene polymorphisms and migraine attack severity and frequency.

Conclusion:

Our study did not show any association between CALCA T-692C gene polymorphism and migraine.

Type
Original Article
Information
Canadian Journal of Neurological Sciences , Volume 40 , Issue 5 , September 2013 , pp. 722 - 725
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1.Ward, TN.Migraine diagnosis and pathophysiology. Continuum (Minneap Minn). 2012;18:753–63.Google ScholarPubMed
2.Weir, GA, Cader, MZ.New directions in migraine. BMC Med. 2011;9:116.CrossRefGoogle ScholarPubMed
3.Goadsby, PJ, Lipton, RB, Ferrari, MD.Migraine-current understanding and treatment. N Engl J Med. 2002;346:257–70.CrossRefGoogle ScholarPubMed
4.Lassen, LH, Haderslev, PA, Jacobsen, VB, Iversen, HK, Sperling, B, Olesen, J.CGRP may play a causative role in migraine. Cephalalgia. 2002;22:54–61.CrossRefGoogle ScholarPubMed
5.Tepper, SJ, Stillman, MJ.Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine. Headache. 2008;48:1259–68.CrossRefGoogle ScholarPubMed
6.Messlinger, K, Lennerz, JK, Eberhardt, M, Fischer, MJ.CGRP and NO in the trigeminal system: mechanisms and role in headache generation. Headache. 2012;52(9):1411–27.CrossRefGoogle ScholarPubMed
7.Powell, KJ, Ma, W, Sutak, M, Doods, H, Quirion, R, Jhamandas, K.Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol. 2000;131:875–84.CrossRefGoogle ScholarPubMed
8.Oku, R, Satoh, M, Fujii, N, Otaka, A, Yajima, H, Takagi, H.Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res. 1987;403:350–4.CrossRefGoogle ScholarPubMed
9.Rossi, SG, Dickerson, IM, Rotundo, RL.Localization of the calcitonin gene-related peptide receptor complex at the vertebrate neuromuscular junction and its role in regulating acetylcholinesterase expression. J Biol Chem. 2003;278:24994–25000.CrossRefGoogle ScholarPubMed
10.Schürks, M.Genetics of migraine in the age of genome-wide association studies. J Headache Pain. 2012;13:1–9.CrossRefGoogle ScholarPubMed
11.Pizza, V, Agresta, A, Agresta, A, et al.Migraine and genetic polymorphisms: an overview. Open Neurol J. 2012;6:65–70.CrossRefGoogle ScholarPubMed
12.Headache Classification Sub-Committee of the International Headache Society International Classification of Headache Disorders, 2nd ed. Cephalgia. 2004;24:1–160.Google Scholar
13.Arulmani, U, Maassenvandenbrink, A, Villalón, CM, Saxena, PR.Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol. 2004;500:315–30.CrossRefGoogle ScholarPubMed
14.Menon, S, Buteri, J, Roy, B, et al.Association study of calcitonin gene-related polypeptide-alpha (CALCA) gene polymorphism with migraine. Brain Res. 2011;1378:119–24.CrossRefGoogle ScholarPubMed
15.Lemos, C, Mendonça, D, Pereira-Monteiro, J, et al.BDNF and CGRP interaction: implications in migraine susceptibility. Cephalalgia. 2010;30:1375–82.CrossRefGoogle ScholarPubMed
16.Luo, XL, Yang, TL, Chen, XP, Li, YJ.Association of CALCA genetic polymorphism with essential hypertension. Chin Med J (Engl). 2008;121:1407–10.CrossRefGoogle ScholarPubMed
17.Buervenich, S, Xiang, F, Sydow, O, et al.Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression. Hum Mutat. 2001;17:435–6.CrossRefGoogle Scholar